default author photo

Alina Danu

Gustave Roussy - Hematology Department

Villejuif

France

SCHOLARLY PAPERS

2

DOWNLOADS

177

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Infectious Complications in Patients Treated with T-Cell Engager for Solid Tumours or Haematological Malignancies, a Descriptive Study from the REISAMIC Registry

Number of pages: 33 Posted: 12 Nov 2024
University of Paris-Saclay - Department of Hematology, Gustave Roussy, Gustave Roussy, Gustave Roussy, University of Paris-Saclay - Institut Pasteur, Gustave Roussy - Hematology Department, Gustave Roussy - Hematology Department, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Comité de Pathologies Thoraciques, Université Paris Saclay - Department of Children and Adolescents Oncology, Department of Pediatric and Adolescent Oncology, Institut Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Gustave Roussy, Aix Marseille Université, Gustave Roussy, University of Paris-Saclay, Gustave Roussy - Drug Development Department (DITEP) and Gustave Roussy - Drug Development Department (DITEP)
Downloads 114 (621,896)

Abstract:

Loading...

T-cell engager, infections, haematological malignancy, solid tumour

2.

Sequence Analyses of Relapsed or Refractory Diffuse Large B-Cell Lymphomas Unravels Three Genetic Subgroups of Patients and GNA3 Mutant as Poor Prognosis Biomarker, Results of LNH-EP1 Study

Number of pages: 35 Posted: 14 Mar 2022
Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Translational Research Hematological Laboratory, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Hematology Department, Gustave Roussy - Hematology Department, Gustave Roussy - Hematology Department, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Hematology Department, Gustave Roussy - Hematology Department, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Medical Imaging Department, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Medical Imaging Department, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Department of Medical Biology and Pathology, Gustave Roussy - Hematology Department, Gustave Roussy - Department of Medical Biology and Pathology, Gustave Roussy - Department of Medical Biology and Pathology, Gustave Roussy - Department of Medical Biology and Pathology, Gustave Roussy - Hematology Department, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), INSERM U1170, Université Paris-Saclay, Gustave Roussy, Gustave Roussy - Department of Medical Biology and Pathology, Gustave Roussy - Translational Research Hematological Laboratory and Gustave Roussy - Drug Development Department (DITEP)
Downloads 63 (933,592)

Abstract:

Loading...

Lymphoma large B-cell diffuse, Molecular sequencing, Prognosis biomarker, Genetic cluster analysis, Guanine nucleotide binding protein (G protein) alpha 13 human